Breast Cancer Trial, Recruiting NCT06642428 Sponsor: Jiuda Zhao Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06642428
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old and are reasonably able to carry out daily activities (confirm with trial site for exact fitness level required)
  • You have been diagnosed with breast cancer, confirmed by a biopsy or tissue test before surgery
  • Your blood test shows that your vitamin D levels are low (below 20 ng/ml)
  • You have not yet received chemotherapy and are planning to have at least 4 rounds of chemotherapy before surgery, with or without targeted therapy
  • You are expected to live for at least 6 months or more
  • You do not have any other serious uncontrolled health conditions at the time of joining
  • Your medical records are complete and up to date
  • You are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • You have previously had invasive breast cancer
  • You have already received any treatment for breast cancer, or taken medication to prevent it
  • You have a known allergy to vitamin D or calcium supplements
  • You have a health condition that affects how your body processes vitamin D or calcium, or that affects your bone health (confirm with trial site for specific conditions)
  • You have taken vitamin D or calcium supplements in the last 3 months
  • You have been diagnosed with another type of cancer
  • You are currently pregnant or breastfeeding
  • You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 869716230893

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiuda Zhao
Registry
ClinicalTrials.gov
Start date
18 October 2024
Est. completion
31 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The objective response rate; The pathological complete response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov